| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Camp4 Therapeutics Corporation
13D/A
Amendment 2
CAMP · 13463J101
|
6.3% |
8/19/2026
Event 8/13/2026
|
|||
| Polaris Management Co. VII, L.L.C. | 4.8% | ||||
| Polaris Partners VII, L.P. | 4.5% | ||||
| Polaris Entrepreneurs' Fund VII, L.P. | 0.3% | ||||
| Polaris Partners GP X, L.L.C. | 1.4% | ||||
| Polaris Partners X, L.P. | 1.4% | ||||
| Amir Nashat | 6.3% | ||||
| Brian Chee | 1.4% | ||||
| Amy Schulman | 1.4% | ||||
|
Camp4 Therapeutics Corporation
13D/A
Amendment 1
CAMP · 13463J101
|
8.4% |
9/11/2025
Event 9/9/2025
|
|||
| Polaris Management Co. VII, L.L.C. | 6.4% | ||||
| Polaris Partners VII, L.P. | 6.0% | ||||
| Polaris Entrepreneurs' Fund VII, L.P. | 0.4% | ||||
| Polaris Partners GP X, L.L.C. | 1.9% | ||||
| Polaris Partners X, L.P. | 1.9% | ||||
| Amir Nashat | 8.4% | ||||
| Brian Chee | 1.9% | ||||
| Amy Schulman | 1.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.